Trigonometrische und barometrische höhenbestimmungen in Württemberg, bezogen auf den einheitlich deutschen normalnullpunkt ... hft. 1, 3, 5, 7, 10-11, 14.

No more published?

Organizational, direct support and general support maintenance repair parts and special tool list for water purification unit, reverse osmosis, 600 GPH trailer mounted, flatbed cargo, 5 ton 4 wheel tandem model Rowpu 600-1, (4610-01-093-2380).

"September 1983."

Organizational maintenance manual : truck, utility, 1/4 ton, 4x4, M151 (2320-542-4783), M151A1 (2320-763-1092), M151A2 (2320-177-9258); truck, utility, 1/4 ton, 4x4, M151A1C (2320-763-1091), M825 (2320-177-9257) with 106 mm recoilless rifle; truck, ambulance, front line, 1/4 ton, 4x4 ....

Includes index.

Operator's manual for truck, cargo, tactical, 1-1/4 ton, 4X4, M1008 (2320-01-123-6827) : truck, cargo, tactical, 1-1/4 ton, 4X4, M1008A1 (2320-01-123-2671) : truck, utility, tactical, 3/4 ton, 4X4, M1009 (2320-01-123-2665) ...

Includes index.

Hand receipt covering content of components of end item (COEI), basic issue items (BII) and additional authorization list (ALL) for truck, cargo, tactical, 1-1/4 ton, 4X4, M1008 (2320-01-123-6827) : truck, cargo, tactical, 1-1/4 ton, 4X4, M1008A1 (2320-01-123-2671) : truck, utility, tactical, 3/4 ton, 4X4, M1009 (2320-01-123-2665) ...

"April 1983."

Organizational maintenance manual for truck, cargo, tactical, 1-1/4 ton, 4X4, M1008 (2320-01-123-6827) : truck, cargo, tactical, 1-1/4 ton, 4X4, M1008A1 (2320-01-123-2671) : truck, utility, tactical, 3/4 ton, 4X4, M1009 (2320-01-123-2665) ...

Includes index.

Direct support and general support maintenance manual for truck, cargo, tactical, 1-1/4 ton, 4x4, M1008 (2320-01-123-6827) : truck, cargo, tactical, 1-1/4 ton, 4x4, M1008A1 (2320-01-123-2671) : truck, utility, tactical, 3/4 ton, 4x4, M1009 (2320-01-2665) ...

"April 1983."

Unit maintenance manual for truck, cargo, tactical, 1-1/4 ton, 4x4, M1008 (2320-01-123-6827), truck, cargo, tactical, 1-1/4 ton, 4x4, M1008A1 (2320-01-123-2671), truck, utility, tactical, 3/4 ton, 4x4, M1009 (2320-01-123-2665), truck, ambulance, tactical, 1-1/4 ton, 4x4, M1010 (2310-01-123-2666) ....

Includes index.

Transportability guidance : Foward Area Alerting Radar system (FAAR) : radar set, AN/MPQ 49, (NSN 1430-00-179-4199), truck, cargo, 1 1/4-ton, M561, (NSN 2320-00-873-5407), trailer, cargo, 3/4-ton, M101A1, (NSN 2330-00-898-6779), test set, radar, AN/MPM 57, (NSN 4935-00-178-0833).

"January 1976."

America annuals of education. v. 1-4, Jan. 18260-Dec. 1829; new ser., v. 1, no. 1-5, Jan.-July 1830; 3d ser., v.1-9, Aug. 1830-Dec. 1839.

From Jan. 1826-July 1830 title reads: American journal of education. In August 1830 the title was changed to American Annuals of Education and instruction. The numbers for August-Dec. 1830, however, were issued both under this later title (as 3d ser., b.1, no 1-4) and under the title American journal and annals of education and instruction, new ser., v.1 of the 3d ser. They are preceded by 24 pages ("Editor's address" and "Sketches of Hofwyl") reprinted from the numbers for Aug.-Dec. 1830) In 1838 the title was shortened to American annuals of education. Editors: 1826-29, Williams Russell.--1830-37, W.C. Woodbridge.--1837--38 W.A. Alcott.

Fragm. lat. III 34 - Liber Sextus Decretalium (1.4.1 - 4; 1.6.43 - 46; 1.22.2 - 3.3; 3.4.23 - 24), ohne Glosse

Trägerband: Inc. qu. 738; Inc. qu. 913; 'Vocabularius Ex quo'; Vorbesitzer: Dominikanerkloster Frankfurt am Main

Non-response to antiviral therapy is associated with obesity and increased hepatic expression of suppressor of cytokine signalling 3 (SOCS-3) in patients with chronic hepatitis C, viral genotype 1

Background: Interferon alpha (IFN-alpha) activated cellular signalling is negatively regulated by inhibitory factors, including the suppressor of cytokine signalling (SOCS) family. The effects of host factors such as obesity on hepatic expression of these inhibitory factors in subjects with chronic hepatitis C virus (HCV) are unknown. Objectives: To assess the independent effects of obesity, insulin resistance, and steatosis on response to IFN-alpha therapy and to determine hepatic expression of factors inhibiting IFN-alpha signalling in obese and nonobese subjects with chronic HCV. Methods: A total of 145 subjects were analysed to determine host factors associated with non-response to antiviral therapy. Treatment comprised IFN-alpha or peginterferon alpha, either alone or in combination with ribavirin. In a separate cohort of 73 patients, real time-polymerase chain reaction was performed to analyse hepatic mRNA expression. Immunohistochemistry for SOCS-3 was performed on liver biopsy samples from 38 patients with viral genotype 1 who had received antiviral treatment. Results: Non-response (NR) to treatment occurred in 55% of patients with HCV genotypes 1 or 4 and 22% with genotypes 2 or 3. Factors independently associated with NR were viral genotype 1/4 (p < 0.001), cirrhosis on pretreatment biopsy (p = 0.025), and body mass index >= 30 kg/m(2) (p = 0.010). Obese subjects with viral genotype 1 had increased hepatic mRNA expression of phosphoenolpyruvate carboxy kinase (p = 0.01) and SOCS-3 (p = 0.047), in comparison with lean subjects. Following multivariate analysis, SOCS-3 mRNA expression remained independently associated with obesity (p = 0.023). SOCS-3 immunoreactivity was significantly increased in obesity (p = 0.013) and in non-responders compared with responders (p = 0.014). Conclusions: In patients with chronic HCV viral genotype 1, increased expression of factors that inhibit interferon signalling may be one mechanism by which obesity reduces the biological response to IFN-alpha.

X-ray crystallographic and theoretical studies of an anticonvulsant enaminone:methyl 4-(4'-bromophenyl)amino-6-methyl-2-oxocyclohex-3-en-1-oate

Objective: The aims of this study were to establish the structure of the potent anticonvulsant enaminone methyl 4-(4′-bromophenyl)amino-6-methyl-2- oxocyclohex-3-en-1-oate (E139), and to determine the energetically preferred conformation of the molecule, which is responsible for the biological activity. Materials and Methods: The structure of the molecule was determined by X-ray crystallography. Theoretical ab initio calculations with different basis sets were used to compare the energies of the different enantiomers and to other structurally related compounds. Results: The X-ray crystal structure revealed two independent molecules of E139, both with absolute configuration C11(S), C12(R), and their inverse. Ab initio calculations with the 6-31G, 3-21G and STO-3G basis sets confirmed that the C11(S), C12(R) enantiomer with both substituents equatorial had the lowest energy. Compared to relevant crystal structures, the geometry of the theoretical structures shows a longer C-N and shorter C=O distance with more cyclohexene ring puckering in the isolated molecule. Conclusion: Based on a pharmacophoric model it is suggested that the enaminone system HN-C=C-C=O and the 4-bromophenyl group in E139 are necessary to confer anticonvulsant property that could lead to the design of new and improved anticonvulsant agents. Copyright © 2003 S. Karger AG, Basel.